Nalaganje...
Correction: Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
Shranjeno v:
| izdano v: | J Immunother Cancer |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883864/ https://ncbi.nlm.nih.gov/pubmed/33579740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001622corr1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|